Business Description
Cardio Diagnostics Holdings Inc. is a Chicago-based company founded in 2017 that creates blood tests and digital tools to help doctors identify and manage heart disease risk in their patients. Its products use genetic and epigenetic science to detect coronary heart disease, predict future cardiac events, and guide treatment decisions. The company serves a range of healthcare providers, including telemedicine platforms, specialty clinics, and employer health programs, as well as pharmaceutical researchers developing new cardiovascular treatments.
